Thursday 16 July 2015

Reducing threshold for statins even further might be cost-effective, study suggests

US study concludes that reducing threshold for statins below 10% 10-year CVD risk threshold seems cost-effective

Related items from OnMedica

Would it be easier to just give everyone statins?
Statins benefit children with familial hypercholesterolaemia
NICE rejects arguments against wider statin use
Statins associated with 46% increased diabetes risk
Statins and dietary changes have saved 20,000 lives
via OnMedica News Read More Here..

No comments:

Post a Comment